Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Mylin Torres, MD, FASTRO

Emory University
Atlanta, GA, United States

Dr. Mylin Torres is a board certified radiation oncologist who specializes in the treatment of breast cancer. She is currently Co-Leader of the Cancer Prevention Control Research Program of Winship Cancer Institute and is Professor of Radiation Oncology. Her research program is dedicated to understanding biology underlying treatment-related side effects and to developing interventions which will improve the life quality of breast cancer survivors. Awards from the Pfizer ASPIRE research program and the Pfizer Global Breast Cancer Research Program/Genentech IIS programs facilitate two of Dr. Torres’ ongoing investigator-initiated multi-institutional trials of novel combinations of systemic therapy with radiation in breast cancer patients with metastatic disease.


Dr. Torres has written and co-authored a number of publications and abstracts. She has received highly competitive grants from the National Cancer Institute (NCI), Radiation Therapy Oncology Group (RTOG), Winship Cancer Institute, and Susan G. Komen to support her research on the detection and treatment of breast cancer therapy-induced toxicities. For her outstanding care of patients, Dr. Torres was awarded the Atlanta Business Chronicle’s Healthcare Heroes Rising Star, the Winship Cancer Institute Above and Beyond Award, and The Winship Annual Mentorship Award. Atlanta Magazine also named her as one of the “Women Making a Mark” in the Atlanta community. She is currently on the Editorial Board for the Journal of Clinical Oncology and serves on the Advisory Committee on Breast Cancer in Young Women for the U.S. based Centers for Disease Control and Prevention (CDC).

Disclosures:

  • Employment: Emory University:Professor:Employee
  • Compensation: Pfizer Oncology: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 11/2021 ;Oncohealth: Consultant, Compensation Payment-End Date: 5/2023 ;Genentech: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 8/2023 ;Pfizer: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Varian Medical Systems: Honoraria-End Date: to present ;Pfizer Oncology: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support, Honoraria-End Date: 11/2021 ;Pfizer: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present
  • Ownership: none
  • Leadership: none

Presentation(s):